Bionano Genomics (BNGO) Income from Continuing Operations (2017 - 2026)
Bionano Genomics (BNGO) posted Income from Continuing Operations of 8303000.0 for Q1 2026, down 144.84% sequentially from 18517000.0 in Q4 2025, and down 167.67% YoY from 12270560.27 in Q1 2025.
Bionano Genomics (BNGO) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Bionano Genomics has reported Income from Continuing Operations for 10 years, with the latest figure at 8303000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 167.67% year-over-year to 8303000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5146000.0 (up 93.88% YoY) and the FY2025 annual result came in at 55000.0, up 100.05% from the prior year.
- Income from Continuing Operations slipped to 8303000.0 in Q1 2026 per BNGO's latest filing, from 18517000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 18517000.0 in Q4 2025 and troughed at 112566000.0 in Q3 2023.
- A 5-year average of 28569882.35 and a median of 31422000.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2023 and 2025: Income from Continuing Operations sank 253.88% in 2023, then soared 190.51% in 2025.
- Over 5 years, Income from Continuing Operations stood at 38677000.0 in 2022, then slipped by 13.48% to 43891000.0 in 2023, then jumped by 53.39% to 20459000.0 in 2024, then jumped by 190.51% to 18517000.0 in 2025, then plunged by 144.84% to 8303000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 8303000.0, 18517000.0, and 8503000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Bionano Genomics | 13.74 Mn | 3.81 Mn | 4.31 Mn | -7.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.42 Mn |
| Mar 31, 2026 | -8.30 Mn |
| Dec 31, 2025 | 18.52 Mn |
| Sep 30, 2025 | -8.50 Mn |
| Jun 30, 2025 | -6.86 Mn |
| Mar 31, 2025 | -3.10 Mn |
| Dec 31, 2024 | -20.46 Mn |
| Sep 30, 2024 | -44.25 Mn |
| Jun 30, 2024 | -16.22 Mn |
| Mar 31, 2024 | -31.42 Mn |
| Dec 31, 2023 | -43.89 Mn |
| Sep 30, 2023 | -112.57 Mn |
| Jun 30, 2023 | -38.91 Mn |
| Mar 31, 2023 | -37.12 Mn |
| Dec 31, 2022 | -38.68 Mn |
| Sep 30, 2022 | -31.81 Mn |
| Jun 30, 2022 | -32.16 Mn |
| Mar 31, 2022 | -29.95 Mn |
| Dec 31, 2021 | -22.95 Mn |
| Sep 30, 2021 | -20.75 Mn |